Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
about
Homocysteine lowering interventions for preventing cardiovascular eventsHomocysteine lowering interventions for preventing cardiovascular eventsAntioxidants in Cardiovascular Therapy: Panacea or False Hope?Hyperhomocysteinaemia in rats is associated with erectile dysfunction by impairing endothelial nitric oxide synthase activity.Contemporary issues surrounding folic Acid fortification initiativesThe COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult ratsRole of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects.The protocols for the 10/66 dementia research group population-based research programme.Evidence based cardiology: emerging approaches in preventing cardiovascular disease.Noninvasive approaches to peripheral vascular disease. What's new in evaluation and treatment?Work and diet-related risk factors of cardiovascular diseases: comparison of two occupational groupsCorrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.Micronutrient deficiencies. A major cause of DNA damage.Targeted metabolomics and mathematical modeling demonstrate that vitamin B-6 restriction alters one-carbon metabolism in cultured HepG2 cells.Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.Nutritional factors in stroke.Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Novel risk factors for stroke: homocysteine, inflammation, and infection.The dietary prevention and treatment of coronary heart disease in the new millennium.Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literatureNovel insights on interactions between folate and lipid metabolism.Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.Vitamin B-6 restriction reduces the production of hydrogen sulfide and its biomarkers by the transsulfuration pathway in cultured human hepatoma cells.Clinical Evidence: Emerging approaches in preventing cardiovascular disease.Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients.Mediterranean diets and cardiovascular disease.The Parkinson's disease death rate: carbidopa and vitamin B6.The Mediterranean-style diet for the prevention of cardiovascular diseases.Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.Metabolite profile analysis reveals association of vitamin B-6 with metabolites related to one-carbon metabolism and tryptophan catabolism but not with biomarkers of inflammation in oral contraceptive users and reveals the effects of oral contraceptHomocysteine and occlusive arterial disease.Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.Metabolomic analysis reveals extended metabolic consequences of marginal vitamin B-6 deficiency in healthy human subjectsModerate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women.Too much folate: a risk factor for cancer and cardiovascular disease?Serum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolismTotal plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence.Royal College of Physicians Intercollegiate Stroke Working Party evidence-based guidelines for the secondary prevention of stroke through nutritional or dietary modification.Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities studyMethylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.
P2860
Q24239981-B649F482-13F1-4D1B-BBC1-CF3EB74713BFQ24244823-9CD2E24F-2149-4586-AE4C-8A6696A394C5Q26776115-50EF2034-DB32-41BE-AEE0-7E7BEA1623FEQ27312470-EFACA4B9-4CAC-4A71-A5E0-8FA8B61215D2Q28083544-8DCF30CF-B0C3-4679-A9CD-DA0AFBD72DB9Q28299609-7C54C508-2FF8-4452-88FD-28B3936974EBQ31720591-D816329D-7424-4CC6-9A3E-25221667024FQ33292026-E26B59FE-D49D-48B5-B6C8-9E8346837681Q33633505-D2270A82-7435-47B4-BA9A-B7DE3503DE70Q33736758-0B9255C2-456C-4D33-82B5-453D02254E3DQ33797678-6A226581-6EC5-4AB1-B8E7-7772D6AB0A2EQ33799086-79E078E0-3DE6-45BC-A1BC-367038264747Q33834311-D21F8C96-66E3-4595-9296-1F54F04C52C0Q33839922-210F8260-E36A-4CD6-9ACF-230685C86AF1Q33955167-9C661008-425F-44C8-9295-67FD27DBDE39Q34015039-76EF9DFF-1C84-49EF-AFFC-D1F427CAD681Q34038098-91FFE680-A8E3-4ACA-BB9E-C6083B6E9E3FQ34107356-CDA0AA8E-2608-4418-9FE5-ADC4F62928A7Q34110796-45EC601D-F284-477F-B107-017C2AD860C0Q34121446-702C0A5A-BEA7-4551-85B1-556A11CBA68CQ34130356-ACBBF927-4EBE-4A05-98F7-7EA5D70ACF0EQ34163053-EA4291D6-809E-4219-81D4-A194EA10A168Q34171909-2385F282-283F-4D55-892E-B479B2ACD492Q34191507-9EFCDED5-CA39-4248-BE5B-B2EC42F80975Q34234631-2A8B6AC9-5BF2-4BCA-9417-8FC1F0409AD2Q34401754-9B3CE599-90BF-4FB1-8BB9-803A2B869151Q34415308-FFFDDA81-8C46-4DF7-9C1E-F7E3003C3229Q34565339-8B969352-0645-4AD4-8D50-80FCB3028CA5Q34577250-FA35EBA2-D749-427E-9A88-0DB492C9662AQ34684231-542984FB-20FE-4053-9BE7-54C05870CEFBQ34703668-0B3E57F7-1469-4104-B1A7-E82475F9A6A7Q34716812-087D0D4D-71D0-4CEF-9AC5-0A04A5E11666Q34775573-DBFDF79A-A8B2-4DB2-BD52-26729895315BQ34802087-2663DBE7-FC4A-4AC0-9FDF-F1AD1E220AACQ34895640-74F71CF5-1967-42D0-AA25-92B5731C6145Q35098847-7191F587-B369-4CAD-9564-1487CEA47D08Q35160971-E98342BF-13DB-4EF4-9AD3-DC95C86AAB31Q35190768-E57A7965-7DB4-453A-A214-FBADEB5C8428Q35302760-C84F179E-5CCC-403E-BD5A-E368AE7D85C9Q35371861-55EC250F-0085-4ADA-9A27-482399440DFD
P2860
Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Low circulating folate and vit ...... disease. European COMAC Group.
@ast
Low circulating folate and vit ...... disease. European COMAC Group.
@en
Low circulating folate and vit ...... disease. European COMAC Group.
@nl
type
label
Low circulating folate and vit ...... disease. European COMAC Group.
@ast
Low circulating folate and vit ...... disease. European COMAC Group.
@en
Low circulating folate and vit ...... disease. European COMAC Group.
@nl
prefLabel
Low circulating folate and vit ...... disease. European COMAC Group.
@ast
Low circulating folate and vit ...... disease. European COMAC Group.
@en
Low circulating folate and vit ...... disease. European COMAC Group.
@nl
P2093
P921
P356
P1433
P1476
Low circulating folate and vit ...... disease. European COMAC Group.
@en
P2093
Brattström L
Palma-Reis R
Robinson K
Witteman J
P304
P356
10.1161/01.CIR.97.5.437
P407
P577
1998-02-01T00:00:00Z